The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
Recruiting
Observational Study
Achalasia, Esophageal
Achalasia
Indocyanine Green (ICG)
Indocyanine Green
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 70 (estimated)
- Sponsor
- Federico II University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim this prospective observational study is to evaluate the role of Indocyanine Green Fluorescence (ICG) in patients with achalasia underwent to Heller-Dor laparoscopic. The main gol are:
* If with use of ICG iatrogenic mucosal leaks can be identified and, if necessary, improve the myotomy.
* Assess the need for postoperative radiographic control using esophagogastric radiography with gastrog…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with achalasia of type I and II
* patients undergoing laparoscopic Heller-Dor
* patients older than 18 years
Exclusion Criteria:
* Patients \<18 years of age;
* Uncooperative patients and/or patients unable to provide informed consent
* ASA ≥4
* BMI ≥30
* Patients p…
Contacts